Clinical Trial Update: Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing voglibose versus glibenclamide added to metformin for glycemic and cardiovascular outcomes in type 2 diabetes patients withou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glibenclamide (glibenclamide)
• Voglibose (voglibose)
• metformin (metformin)

Snippet

Sponsor: University of Zambia | Conditions: Diabetes Mellitus Type 2 Without Complication | Phase 3 | Status: UNKNOWN